HIV treatment optimism should be balanced by need for "even more aggressive" therapies -- Harvard's Hammer.
Executive Summary
HIV TREATMENT OPTIMISM MUST BE "TEMPERED" TO AVOID "COMPLACENCY" in the effort to develop AIDS treatments with long-term effectiveness, Harvard Medical School researcher Scott Hammer, MD, Harvard Medical School, cautioned in his keynote speech of the XI International Conference on AIDS in Vancouver. He suggested that the current level of excitement should serve as a catalyst to "spur even more intensive drug development efforts and the testing of even more aggressive therapeutic approaches."